Last reviewed · How we verify

NCT05054192

Reliability and Validity of Modified Four Square Step Test

Status unknown Last updated 23 September 2021
What this trial tests

trial in Total Hip Arthroplasty in 28 participants. Status unknown.

Timeline
1 September 2021
Primary endpoint
1 September 2022
1 September 2023

Quick facts

Lead sponsorAfyonkarahisar Health Sciences University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment28
Start date1 September 2021
Primary completion1 September 2022
Estimated completion1 September 2023
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Afyonkarahisar Health Sciences University

Who can join

Adults 18 to 85, any sex, with Total Hip Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Functional improvements are reached in patients with primary total hip arthroplasty compared to the pre-operative term however some problems as continued range of motion limitations, loss of joint proprioception sensation, and resulting balance and gait disorders may result in failure of the Four Square Step Test. Therefore, the need for the apply of the Modified Four Square Step Test in individuals with primary THA is necessary. The aim of this study is to evaluate the test-retest reliability, concurrent validity and minimal detectable change of the Modified Four Square Step Test in individuals with primary total hip arthroplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Total Hip Arthroplasty

Currently open trials in the same condition.

Other Afyonkarahisar Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05054192.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing